Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers-Reference-Cited by-同舟云学术

Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers

Published:2021-09-20 Issue:5 Volume:15 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Ito Masaaki¹,Hiwasa Takaki¹,Oshima Yoko²,Yajima Satoshi²,Suzuki Takashi²,Nanami Tatsuki²,Sumazaki Makoto²,Shiratori Fumiaki²,Funahashi Kimihiko²,Takizawa Hirotaka³,Kashiwado Koichi⁴,Tochigi Naobumi⁵,Shimada Hideaki¹

Affiliation:

1. Department of Clinical Oncology, Toho University Graduate School of Medicine, Ota‑ku, Tokyo 143‑8541, Japan

2. Department of Gastroenterological Surgery, Toho University School of Medicine, Ota‑ku, Tokyo 143‑8541, Japan

3. Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chuo-ku, Chiba 260‑0025, Japan

4. Department of Neurology, Kashiwado Hospital, Chuo-ku, Chiba 260‑0854, Japan

5. Department of Surgical Pathology, Toho University School of Medicine, Ota‑ku, Tokyo 143‑8541, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases;International Journal of Molecular Sciences;2024-04-30

2. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma;Cancer Science;2024-04-18

3. Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review);Cancers;2023-12-22

4. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer;Frontiers in Cardiovascular Medicine;2023-02-10

5. Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment;Chinese Journal of Cancer Research;2023